Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
Tae In Wi,1,* Ji Eun Won,1,* Chan Mi Lee,1 Jeong-Won Lee,2 Tae Heung Kang,1 Byung Cheol Shin,3 Hee Dong Han,1 Yeong-Min Park1 1Department of Immunology, School of Medicine, Konkuk University, Chungju 380-701, South Korea; 2Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan...
Main Authors: | Wi TI, Won JE, Lee CM, Lee JW, Kang TH, Shin BC, Han HD, Park YM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-combination-therapy-with-linalool-and-doxorubicin-encapsul-peer-reviewed-article-IJN |
Similar Items
-
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
by: Singh S
Published: (2018-03-01) -
A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review
by: Yik Hoe Ngan, et al.
Published: (2016-01-01) -
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
by: Alberto Gabizon, et al.
Published: (2023-11-01) -
Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
by: Mihad Ibrahim, et al.
Published: (2022-01-01) -
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
by: Kenan Aloss, et al.
Published: (2023-03-01)